Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: An analysis of surgical morbidity and mortality

Journal of Thoracic and Cardiovascular Surgery

Volumn 148, Issue 1, 2014, Pages 30-35

  Burt, Bryan M ^a   Cameron, Robert B ^b   Mollberg, Nathan M ^c   Kosinski, Andrzej S ^d   Schipper, Paul H ^e   Shrager, Joseph B ^a   Vigneswaran, Wickii T ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COMORBIDITY; CYTOREDUCTIVE SURGERY; DATA BASE; DECORTICATION; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTUBATION; LUNG FUNCTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PLEURA MESOTHELIOMA; PLEURECTOMY; PREOPERATIVE CARE; PRIORITY JOURNAL; REOPERATION; SURGICAL MORTALITY; THORAX SURGERY;

AGED; DATABASES, FACTUAL; FEMALE; HOSPITALS, HIGH-VOLUME; HOSPITALS, LOW-VOLUME; HUMANS; LOGISTIC MODELS; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PLEURAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SOCIETIES, MEDICAL; THORACIC SURGICAL PROCEDURES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84902549356     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.03.011     Document Type: Article

References (16)

1. N. Merritt, C.J. Blewett, J.D. Miller, W.F. Bennett, J.E. Young, and J.D. Urschel Survival after conservative (palliative) management of pleural malignant mesothelioma J Surg Oncol 78 2001 171 174
2. N.J. Vogelzang, J.J. Rusthoven, J. Symanowski, C. Denham, E. Kaukel, and P. Ruffie et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2003 2636 2644
3. V. Rusch, E.H. Baldini, R. Bueno, M. De Perrot, R. Flores, and S. Hasegawa et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass J Thorac Cardiovasc Surg 145 2013 909 910
4. E.K. Park, K. Takahashi, T. Hoshuyama, T.J. Cheng, V. Delgermaa, and G.V. Le et al. Global magnitude of reported and unreported mesothelioma Environ Health Perspect 119 2011 514 518
5. V. Delgermaa, K. Takahashi, E.K. Park, G.V. Le, T. Hara, and T. Sorahan Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008 Bull World Health Organ 89 2011 716 724
6. R.M. Flores, H.I. Pass, V.E. Seshan, J. Dycoco, M. Zakowski, and M. Carbone et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 2008 620 626
7. V.W. Rusch, D. Giroux, C. Kennedy, E. Ruffini, A.K. Cangir, and D. Rice et al. Initial analysis of the international association for the study of lung cancer mesothelioma database J Thorac Oncol 7 2012 1631 1639
8. T. Treasure, L. Lang-Lazdunski, D. Waller, J.M. Bliss, C. Tan, and J. Entwisle et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study Lancet Oncol 12 2011 763 772
9. W. Weder, R.A. Stahel, P. Baas, U. Dafni, M. de Perrot, and B.C. McCaughan et al. The MARS feasibility trial: conclusions not supported by data Lancet Oncol 12 2011 1093 1094
10. J.M. Bliss, G. Coombes, L. Darlison, J. Edwards, J. Entwisle, and L. Kilburn et al. The MARS feasibility trial: conclusions not supported by data - Authors' reply Lancet Oncol 12 2011 1094 1095
11. C.Q. Cao, T.D. Yan, P.G. Bannon, and B.C. McCaughan A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma J Thorac Oncol 5 2010 1692 1703
12. E. Teh, F. Fiorentino, C. Tan, and T. Treasure A systematic review of lung-sparing extirpative surgery for pleural mesothelioma J R Soc Med 104 2011 69 80
13. W. Weder, R.A. Stahel, J. Bernhard, S. Bodis, P. Vogt, P. Ballabeni Swiss Group for Clinical Cancer Research Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma Ann Oncol 18 2007 1196 1202
14. L.M. Krug, H.I. Pass, V.W. Rusch, H.L. Kindler, D.J. Sugarbaker, and K.E. Rosenzweig et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma J Clin Oncol 27 2009 3007 3013
15. D.J. Sugarbaker, R.M. Flores, M.T. Jaklitsch, W.G. Richards, G.M. Strauss, and J.M. Corson et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63
16. B.I. Hiddinga, and J.P. van Meerbeeck Surgery in mesothelioma - where do we go after Mars? J Thorac Oncol 8 2013 525 529